Wang Hong-Yu, Song Jian, Gao Fei, Duan Xu-Dong, Gao Xuan, Wang Yuan, Cheng Hong-Bo, Nan Cheng-Rui, Zhao Di
Department of Neurosurgery, Tangshan Gongren Hospital, Tangshan, Hebei.
Department of Neurosurgery, The Second Hospital of Hebei Medical University.
Medicine (Baltimore). 2019 Aug;98(33):e16821. doi: 10.1097/MD.0000000000016821.
Aneurysmal subarachnoid hemorrhage (SAH) is a complex neurovascular syndrome with high disability and mortality. SAH patients may be managed with surgical clipping or coil embolization. In this study, we provided a real-world analysis of the outcome and prognostic factors of aneurysmal SAH in patients treated with coil embolization or microsurgical clipping.We retrospectively analyzed the medical records of aneurysmal SAH patients (n = 583) who underwent treatment at the First Hospital and the Second Hospital of Hebei Medical University, and Tangshan Worker's Hospital in China. All patients were evaluated by a combined neurosurgery and interventional neuroradiology team. Microsurgical aneurysmal clipping was performed using the skull base approach, while coil embolization was performed with bare platinum coils (with or without balloon assistance). The primary outcome was the Glasgow Outcome Scale (GOS) score at discharge.A total of 583 patients were included in this study, of which 397 (68.1%) of them underwent clipping and 186 (31.9%) received coil embolization. The patient cohort consisted of both poor grade and good grade aneurysmal SAH: 441 (75.6%) patients had good-grade (Hunt and Hess grade II or III) and 142 (24.4%) had poor grade (Hunt and Hess grade IV or V). Overall, 123 (21%) patients had unfavorable neurologic outcome (GOS score 1-3) and 460 (78.9%) patients had favorable neurologic outcome (GOS score 4 or 5). The mean GOS score at discharge was comparable for patients who underwent clipping and those received coil embolization (P > .05). Multivariate analysis showed that clipping only [OR (95%CI): 0.03 (0.01, 0.36); P = .000] and clipping with CSF drainage [OR (95%CI): 0.41 (0.18, 0.89); P = .001] were independent factors of a favorable outcome in patients with aneurysmal SAH. Coil embolization with hematoma removal [OR (95%CI): 0.03 (0.01, 0.36); P = .000] was also an independent determinant of a favorable outcome. High baseline Fisher grades were associated with significantly increased risk of an unfavorable outcome [OR (95%CI): 2.08 (1.30, 3.33); P = .002].Our findings suggested that both coil embolization and microsurgical clipping are viable treatment options for aneurysmal SAH patients. Procedures, such as CSF drainage and hematoma removal, performed in parallel with coil embolization and chipping should be considered when treating individual patients.
动脉瘤性蛛网膜下腔出血(SAH)是一种具有高致残率和死亡率的复杂神经血管综合征。SAH患者可采用手术夹闭或弹簧圈栓塞治疗。在本研究中,我们对接受弹簧圈栓塞或显微手术夹闭治疗的动脉瘤性SAH患者的结局和预后因素进行了真实世界分析。我们回顾性分析了在中国河北医科大学第一医院、第二医院以及唐山工人医院接受治疗的动脉瘤性SAH患者(n = 583)的病历。所有患者均由神经外科和介入神经放射学联合团队进行评估。采用颅底入路进行显微手术动脉瘤夹闭,而使用裸铂金弹簧圈(有或无球囊辅助)进行弹簧圈栓塞。主要结局是出院时的格拉斯哥预后评分(GOS)。
本研究共纳入583例患者,其中397例(68.1%)接受了夹闭治疗,186例(31.9%)接受了弹簧圈栓塞。患者队列包括低级别和高级别动脉瘤性SAH:441例(75.6%)患者为高级别(Hunt和Hess分级II或III级),142例(24.4%)为低级别(Hunt和Hess分级IV或V级)。总体而言,123例(21%)患者神经功能结局不佳(GOS评分1 - 3),460例(78.9%)患者神经功能结局良好(GOS评分4或5)。接受夹闭治疗和接受弹簧圈栓塞治疗的患者出院时的平均GOS评分相当(P > 0.05)。多因素分析显示,单纯夹闭[比值比(95%置信区间):0.03(0.01,0.36);P = 0.000]和夹闭联合脑脊液引流[比值比(95%置信区间):0.4(0.18,0.89);P = 0.001]是动脉瘤性SAH患者良好结局的独立因素。弹簧圈栓塞联合血肿清除[比值比(95%置信区间):0.03(0.01,0.36);P = 0.000]也是良好结局的独立决定因素。高基线Fisher分级与不良结局风险显著增加相关[比值比(置信区间):2.08(1.30,3.33);P = 0.002]。
我们的研究结果表明,弹簧圈栓塞和显微手术夹闭都是动脉瘤性SAH患者可行的治疗选择。在治疗个体患者时,应考虑与弹簧圈栓塞和夹闭同时进行的诸如脑脊液引流和血肿清除等操作。